CGNX (NASDAQ: CGNX) discloses option‑linked sales and $7.4M reported proceeds
Rhea-AI Filing Summary
CGNX reported proposed sales of common stock under Rule 144 and disclosed recent dispositions. The notice lists intended sales of 6,100, 10,000 and 25,500 shares tied to option grants, and two completed dispositions in the past three months of 14,881 shares for $850,554.00 and 98,122 shares for $6,554,765.00.
The filing identifies the transactions as issuer-related option exercises and records the broker as Robert W Baird & Co on 05/12/2026. Timing and cash‑flow treatment for the planned sales are shown as 05/12/2026.
Positive
- None.
Negative
- None.
Insights
Rule 144 notice of planned issuer-related dispositions and recent sales.
The filing lists planned sales of vested option shares (6,100; 10,000; 25,500) and reports two recent dispositions: 14,881 shares for $850,554.00 and 98,122 shares for $6,554,765.00. The broker is identified as Robert W Baird & Co.
These entries are procedural disclosures under Rule 144; cashflow treatment and any resale mechanics are tied to the option grants and the broker instructions shown. Subsequent filings would show settlement details if relevant.